New Elite Feature: Chart Templates — Your indicators and design everywhere on Finviz

Cartesian Therapeutics, Inc.

Contributing Author

Recent Articles by Cartesian Therapeutics, Inc.

Mar-09	Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update RNAC +31.68% GlobeNewswire
Feb-23	Cartesian Therapeutics to Participate in Upcoming Investor Conferences RNAC GlobeNewswire
Feb-03	Cartesian Therapeutics Announces New Employment Inducement Grants RNAC GlobeNewswire
Jan-09	Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook RNAC GlobeNewswire
Jan-06	Cartesian Therapeutics Announces New Employment Inducement Grants RNAC GlobeNewswire
Dec-18	Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors RNAC GlobeNewswire
Nov-13	Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis RNAC GlobeNewswire
Nov-06	Cartesian Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update RNAC GlobeNewswire
Oct-30	Cartesian Therapeutics Announces New Employment Inducement Grants RNAC GlobeNewswire
Oct-30	Cartesian Therapeutics Announces Carsten Brunn, Ph.D., Named as Chairman of the Company's Board of Directors RNAC GlobeNewswire
Oct-03	Cartesian Therapeutics Announces New Employment Inducement Grant RNAC GlobeNewswire
Aug-28	Cartesian Therapeutics to Participate in Upcoming Investor Conferences RNAC GlobeNewswire
Aug-07	Cartesian Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update RNAC -6.56% GlobeNewswire
Aug-05	Cartesian Therapeutics Announces New Employment Inducement Grants RNAC -5.21% GlobeNewswire
Jun-03	Cartesian Therapeutics Announces New Employment Inducement Grants RNAC GlobeNewswire
May-30	Cartesian Therapeutics Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis RNAC GlobeNewswire
May-13	Cartesian Therapeutics to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ RNAC GlobeNewswire
May-08	Cartesian Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update RNAC GlobeNewswire
May-02	Cartesian Therapeutics Announces New Employment Inducement Grants RNAC GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)